Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan

• Autors principals: Hideki Houzen (Autor), Takahiro Kano (Autor), Kazuhiro Horiuchi (Autor), Masahiro Wakita (Autor), Azusa Nagai (Autor), Ichiro Yabe (Autor)
• Format: Llibre
• Publicat: MDPI AG, 2021-07-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Reports on the long-term survival effect of edaravone, which was approved for the treatment of amyotrophic lateral sclerosis (ALS) in 2015 in Japan, are rare. Herein, we report our retrospective analysis of 45 consecutive patients with ALS who initially visited our hospital between 2013 and 2018. Of...